Low molecular weight heparins for thromboprophylaxis during induction chemotherapy in patients with multiple myeloma. [electronic resource]
- Klinicka onkologie : casopis Ceske a Slovenske onkologicke spolecnosti 2011
- 281-6 p. digital
Publication Type: Journal Article
0862-495X
Antineoplastic Agents--adverse effects Female Heparin, Low-Molecular-Weight--therapeutic use Humans Male Middle Aged Multiple Myeloma--complications Risk Factors Venous Thrombosis--etiology